Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Britt Van De Craen

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 10, 2012
Glycosylation influences the stability of human plasminogen activator inhibitor-1Britt Van De Craen, Paul J Declerck, Ann Gils
Thrombosis Research|July 18, 2012
The Biochemistry, Physiology and Pathological roles of PAI-1 and the requirements for PAI-1 inhibition in vivoBritt Van De Craen, Paul J Declerck, Ann Gils
Thrombosis Research|December 20, 2011
Maximal PAI-1 inhibition in vivo requires neutralizing antibodies that recognize and inhibit glycosylated PAI-1Britt Van De Craen, Ilse Scroyen, Christine Vranckx, et al.
Journal of Structural Biology|March 17, 2010
Subtle structural differences between human and mouse PAI-1 reveal the basis for biochemical differencesMaarten Dewilde, Britt Van De Craen, Griet Compernolle, et al.
Thrombosis Research|March 12, 2011
Characterization of a panel of monoclonal antibodies toward mouse PAI-1 that exert a significant profibrinolytic effect in vivoBritt Van De Craen, Ilse Scroyen, Rana Abdelnabi, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 10, 2012
Glycosylation influences the stability of human plasminogen activator inhibitor-1Britt Van De Craen, Paul J Declerck, Ann Gils
Thrombosis Research|July 18, 2012
The Biochemistry, Physiology and Pathological roles of PAI-1 and the requirements for PAI-1 inhibition in vivoBritt Van De Craen, Paul J Declerck, Ann Gils
Thrombosis Research|December 20, 2011
Maximal PAI-1 inhibition in vivo requires neutralizing antibodies that recognize and inhibit glycosylated PAI-1Britt Van De Craen, Ilse Scroyen, Christine Vranckx, et al.
Journal of Structural Biology|March 17, 2010
Subtle structural differences between human and mouse PAI-1 reveal the basis for biochemical differencesMaarten Dewilde, Britt Van De Craen, Griet Compernolle, et al.
Thrombosis Research|March 12, 2011
Characterization of a panel of monoclonal antibodies toward mouse PAI-1 that exert a significant profibrinolytic effect in vivoBritt Van De Craen, Ilse Scroyen, Rana Abdelnabi, et al.
Pageof 1